Inflammation and Wound Healing: The Role of Bacteria in the Immuno-Regulation of Wound Healing

International Journal of Lower Extremity Wounds

Volumn 3, Issue 4, 2004, Pages 201-208

  Jones, Stuart G ^a   Edwards, Ruth ^a   Thomas, David W ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

bacteria; chronic wounds; inflammation

Indexed keywords

EID: 84993782387     PISSN: 15347346     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534734604271810     Document Type: Article

References (45)

1. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-852.
2. Moseley R, Stewart JE, Stephens P, et al. Extracellular matrix metabolites as potential biomarkers of disease activity in wound fluid: lessons learned from other inflammatory diseases. Br J Dermatol 2004; 150: 401-413.
3. Merkkes JR, Loots MAM, Van Der Wal AC, et al. Causes, investigation and treatment of leg ulceration. Br J Dermatol 2003; 148: 388-401.
4. Loots MA, Lamme EN, Zeegelaar J, et al. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. Trends Biochem 2001; 111: 1027-1035.
5. Mendez MV, Stanley A, Phillips T, et al. Fibroblasts cultured from distal lower extremities in patients with venous reflux display cellular characteristics of senescence. J Vasc Surg 1998; 28: 1040-1050.
6. Hammad LF. A study of the mechanical and microcirculatory properties of skin subject to venous ulceration, PhD thesis, University of Southampton, 2000.
7. Stvrtinova V, Jahnova E, Weissova S, et al. Inflammatory mechanisms involving neutrophils in chronic venous insufficiency of lower limbs. Bratisl Lek Listy 2001; 102: 235-239.
8. Smith PD. Neutrophil activation and mediators of inflammation in chronic venous insufficiency. J Vasc Res 1999; 36(Suppl 1):24-36.
9. Falanga V, Eaglestein WH. The “trap” hypothesis of venous ulceration. Lancet 1993; 341: 1006-1008.
10. Ågren MS, Eaglstein WH, Ferguson MW, et al. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol (Stockh) 2000; 210: 3-17.
11. Pappas PJ, Falleck SR, Garcia A, et al. Role of leukocyte activation in patients with venous stasis ulcers. J Surg Res 1995; 59: 553-559.
12. Powell CC, Rohrer MJ, Barnard MR, et al. Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation. J Vasc Surg 1999; 30: 844-851.
13. Lerman OZ, Galiano RD, Armour A, et al. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 2003; 162: 303-312.
14. Pierce GF. Inflammation in nonhealing diabetic wounds: the space time continuum does matter. Am J Pathol 2001; 159: 399-403.
15. Pitre DA, Seifert JLL, Bauer JA. Perineurium inflammation and altered connexin isoform expression in a rat model of diabetes related peripheral neuropathy. Neurosci Lett 2001; 303: 67-71.
16. Kelkar P, Masood M, Parry GJ. Distinctive pathological findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology 2000; 55: 83-88.
17. Walmsley D, Wiles PG. Myogenic microvascular responses are impaired in long-duration type 1 diabetes. Diabet Med 1990; 7: 222-227.
18. Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med 1996; 13: 967-972.
19. Brown DL, Kao WW, Greenhalgh DG. Apoptosis down-regulates inflammation under the advancing epithelial wound edge: delayed patterns in diabetes and improvement with topical growth factors. Surgery 1997; 121: 372-380.
20. Jünger M, Steins A, Hahn M, et al. Microcirculatory dysfunction in chronic venous insufficiency (CVI). Microcirculation 2000; 7: s3-s12.
21. Stephens P, Wall IB, Wilson MJ, et al. Anaerobic cocci populating the deep tissues of chronic wounds impair cellular wound healing responses in vitro. Br J Dermatol 2003; 148: 456-466.
22. Laato M, Ninikoski J, Lundberg C, et al. Inflammatory reaction and blood flow in experimental wounds inoculated with Staphylococcus aureus. Eur Surg Res 1998; 20: 33-38.
23. Smith PD. Update on chronic-venous-insufficiency-induced inflammatory processes. Angiology 2000; 52(Suppl 1):S35-S42.
24. Edwards RE, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis 2004; 17: 91-96.
25. Wall IB, Davies CE, Hill KE, et al. Potential role of anaerobic cocci in impaired human wound healing. Wound Repair Regen 2002; 10: 346-353.
26. Cutting KF, Harding KG. Criteria to identify wound infection. J Wound Care 1994; 3: 198-201.
27. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systemic approach to wound management. Wound Repair Regen 2003; 11(Suppl 1):S1-S28.
28. Davies CE, Wilson MJ, Hill KE, et al. The use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen 2001; 9: 332-340.
29. Dow G, Browne A, Sibbald RG. Infection in chronic wounds: controversies in diagnosis and treatment. Ostomy Wound Manage 1999; 45: 23-40.
30. Elek SD. Experimental staphylococcal infections in the skin of man. Ann N Y Acad Sci 1956; 65: 85-90.
31. Allen HE, Edgerton MT, Rodeheaver GT, et al. Skin dressings in the treatment of contaminated wounds. Am J Surg 1973; 126: 45-48.
32. Sapico F, Canawati H, Witte J, et al. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J Clin Microbiol 1980; 12: 413-420.
33. Mertz PM. Cutaneous biofilms: friend or foe? Wounds 2003; 15: 129-132.
34. Serralta VW, Harrison-Balestra C, Cazzagnia AL, et al. Lifestyles of bacteria in wounds: presence of biofilms? Wounds 2001; 13: 29-34.
35. Konturek PC, Bzozowski T, Konturek SJ, et al. Influence of bacterial lipopolysaccharide on healing of chronic experimental ulcer in rat. Scand J Gastroenterol 2001; 36: 1239-1247.
36. Power C, Wang JH, Sookai S, et al. Bacterial wall products induce down regulation of vascular endothelial growth factor receptors on endothelial cells via a CD14-dependant mechanism: implications for surgical wound healing. J Surg Res 2001; 101: 138-145.
37. Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen 1996; 4: 321-325.
38. Nickoloff BJ. Cutaneous dendritic cells in the crossfire between innate and adaptive immunity. J Dermatol Sci 2002; 29: 159-165.
39. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001; 13: 85-94.
40. Mayer-Scholl A, Averhof P, Zychlinsky A. How do microbes and pathogens interact? Curr Opin Microbiol 2004; 7: 62-66.
41. Park JE, Barbul A. Understanding the role of immune regulation in wound healing. Am J Surg 2004; 187: 11S-16S.
42. Medzhitov R. Toll-like receptors and innate immunity. Nature Rev Immunol 2001; 1: 135-145.
43. Takeda K, Akira S. Roles of Toll-like receptors in innate immune responses. Genes Cells 2001; 6: 733-742.
44. Sabroe I, Read RC, Whyte MKB, et al. Toll-like receptors in health and disease: complex questions remain. J Immunol 2003; 171: 1630-1635.
45. Pukstadt BS, Ryan L, Thomas DW. An investigation of Toll-like receptor interaction with bacteria in the pathogenesis of chronic leg ulcers. 2nd World Union of Wound Healing Societies’ Meeting, July 8- July 13, 2004.